High expression of serum TFF1 is related to an increased risk of gastric, lung, pancreatic and breast cancers.[55] Huang et al[56] found that GC patients had higher levels of serum TFF1 than controls and patients with chronic non-atrophic gastritis. Here, TFF1 is linked to breast cancer.